Sanofis alirocumab improves cardiovascular event rate over statins

Sanofi’s alirocumab improves cardiovascular event rate over statins

Original Article: Sanofi’s alirocumab improves cardiovascular event rate over statins

More From BioPortfolio on "Sanofi’s alirocumab improves cardiovascular event rate over statins"